Your browser doesn't support javascript.
loading
Nanoplatform-based natural products co-delivery system to surmount cancer multidrug-resistant.
Liang, Yan; Liu, Ze-Yun; Wang, Ping-Yu; Li, You-Jie; Wang, Ran-Ran; Xie, Shu-Yang.
Afiliación
  • Liang Y; Department of Physiology and Pathophysiology, School of Basic Medicine, Qingdao University, QingDao, ShanDong 266071, PR China; Department of Biochemistry and Molecular Biology, Binzhou Medical University, YanTai, ShanDong 264003, PR China.
  • Liu ZY; School of International Studies, Binzhou Medical University, YanTai, ShanDong 264003, PR China.
  • Wang PY; Department of Biochemistry and Molecular Biology, Binzhou Medical University, YanTai, ShanDong 264003, PR China.
  • Li YJ; Department of Biochemistry and Molecular Biology, Binzhou Medical University, YanTai, ShanDong 264003, PR China.
  • Wang RR; Department of Biochemistry and Molecular Biology, Binzhou Medical University, YanTai, ShanDong 264003, PR China.
  • Xie SY; Department of Physiology and Pathophysiology, School of Basic Medicine, Qingdao University, QingDao, ShanDong 266071, PR China; Department of Biochemistry and Molecular Biology, Binzhou Medical University, YanTai, ShanDong 264003, PR China. Electronic address: shuyangxie@aliyun.com.
J Control Release ; 336: 396-409, 2021 08 10.
Article en En | MEDLINE | ID: mdl-34175367

Texto completo: 1 Colección: 01-internacional Asunto principal: Productos Biológicos / Neoplasias / Antineoplásicos Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Control Release Asunto de la revista: FARMACOLOGIA Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Asunto principal: Productos Biológicos / Neoplasias / Antineoplásicos Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Control Release Asunto de la revista: FARMACOLOGIA Año: 2021 Tipo del documento: Article